“COVID-19 has undoubtedly changed all of our lives and brought much of the world to a standstill,” says Sharon Chan, Head, JLABS @ Shanghai, Johnson & Johnson, “but it has also brought many opportunities with it, especially across digital healthcare.”

Digital transformation has significantly accelerated as a result of the pandemic, especially in the healthcare arena. There has been a move towards tele-medicine, online medical service, and personalized diagnosis and treatment, and experts at JOhn & Johnson say they expect consultations, diagnosis, and monitoring to become more convenient and quicker through digital technology. As a result, there has never been a better time for forward-thinking start-ups to make a difference in healthcare by developing and delivering innovative tech solutions.

Click here for the 2020 Tech and Innovation Summit agenda

Johnson & Johnson Innovation – JLABS @ Shanghai provides an important platform for these start-ups to thrive by offering the resources they need on their journey to bringing new solutions to patients.

On September 17 at the AmCham China Technology and Innovation Summit, Johnson & Johnson's Sharon Chan will lead a discussion with some of the leading start-up CEOs in Johnson & Johnson’s global network of JLABS resident companies to hear more about how open innovation is shaping the future of healthcare in a post-pandemic world. Joining Chan on the panel are Hailiang Shi, CEO & Co-Founder of Live2Life Health Tech; Nawal Roy, Founder & CEO of Holmusk; and Alex Zhavoronkov, CEO of Insilico Medicine.

Click here for the full list of 2020 Tech and Innovation Summit speakers.

Join us on September 17 to hear the latest from Sharon Chan and Johnson & Johnson, and to explore how to navigate through the uncertainties brought by COVID-19.